DrugPoll.com is a Polls & Survey Intelligence platform under the eCorp network. Its stated value proposition is to “reach the right audience, capture real signals, and turn responses into decisions.” Based on the captured content, it looks more like a landing page for an early-stage research product recruiting initial members than a fully developed SaaS website with complete information.
Its core workflow is built around three steps: designing surveys, reaching respondents, and taking action based on results. Feature-wise, it includes audience intelligence, automated polling, and insight analysis. Audience intelligence emphasizes targeted reach, scoring, signals, and demographic context; automated polling includes real-time response collection, weighting, and significance testing; and the analytics side offers live results, cross-tabs, and predictive modeling. Templates cover use cases such as politics, market research, customer feedback, and employee surveys. Respondents can come from verified audience panels, or users can import their own lists.
The page repeatedly mentions “20,000+ polls fielded” and “Global Survey Network,” and also displays “2,400+ members joined this week.” These figures suggest that the product is trying to highlight the scale and activity of its network. However, the main content does not disclose details such as panel sources, country distribution, anti-fraud measures, sample quality control, privacy compliance, or statistical methodology. For serious market research or healthcare/pharma-related research, further verification would therefore be necessary.
Pricing information is limited. The page clearly states “Free forever for early members,” “Free to start,” and “No credit card required,” indicating that early members can register for free permanently without a credit card. However, it does not disclose official plans, sample purchasing costs, seat limits, export restrictions, enterprise options, or support services.
The advantages are a clear positioning and an end-to-end workflow covering questionnaire design, audience reach, and analysis. The early free offer lowers the barrier to trying it, and features such as cross-tabs, weighting, and significance testing can be valuable for marketing insights. The drawbacks are the lack of public information at this stage: there are no product screenshots, customer cases, support channels, compliance explanations, or integration lists. The agent information only shows newsletter- and pageview-related endpoints, and does not yet demonstrate the ecosystem integrations expected from a mature survey platform.
It is suitable for teams working on market research, customer insights, employee surveys, and rapid public-opinion or product-hypothesis validation, especially small teams willing to experiment with early-stage tools. Access from China, payment methods, and localization support are not mentioned in the main content, so they should be considered unknown. In China, comparable options include 问卷星 and 腾讯问卷; mature international alternatives include SurveyMonkey, Qualtrics, and Typeform.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on drugpoll.com official site.
drugpoll.com is an Unknown Marketing & SEO provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach drugpoll.com directly.